Skip to main content
EuroGCT
Menu
Close
Help and support
Help and support
FAQ's
Glossary
FAQ's
How is the safety of a new gene therapy determined?
How are gene and cell therapies different to 'traditional' therapies?
Where do embryonic stem cells for research come from?
How is the production of gene and cell therapies different to traditional treatments?
Why do we need gene and cell therapies? How are they different from traditional medicines and treatments?
What is genetic testing?
Is it ethical to use animals in health and scientific research?
What are the roles of regulators in the development of gene and cell therapies?
See all FAQs
Glossary
Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising
Antibody
See full Glossary
Search
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Condition
Blood disorders
Sickle Cell Disease
Cardiovascular Disease
Heart Disease
Stroke
Bowel Disease
Cancer
Cystic Fibrosis
Eye Disease
Immune Conditions
Diabetes
Multiple Sclerosis
Kidney Disease
Liver Disease
Lung Disease
Bone and Muscle Conditions
Muscular Dystrophy
Spinal Cord Injuries
Neurological Disorders
Alzheimer's Disease
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Spinal Muscular Atrophy
Skin
Epidermolysis Bullosa
Reproduction and Fertility
Cord Blood
Rare Diseases
Theme
Cell and Gene Fundamentals
Blood Stem Cells
Cord Blood
Embryonic Stem Cells
iPS cells
MSCs
Skin Stem Cells
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
CAR-T Therapy
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Gene Editing
Reprogramming
Ethics and Society
Patient Involvement
Policy & Regulation
Unproven Treatments
Factsheets
Spotlight on Research
Main navigation
Discover
Discover
Educational Resources Directory
INTENS
LEARN
Research Pathways
Research Pathways
EuroGCT Key Resources
ATMP Engage
CARTALLEU
Actors and Network database
About Us
Contact
Breadcrumb
Home
Current and Potential Uses
Current and Potential Uses
Resources & Factsheets
From disease to cure: the story of an outstanding scientific result
Related Topics
Immune Conditions
Rare Diseases
Current and Potential Uses
Gene Editing
Gene Therapy
English
Stem Cell Evidence Library
Related Topics
Blood Stem Cells
Cell Therapy
Current and Potential Uses
Research
What is CAR T-cell therapy?
Related Topics
Blood disorders
Cancer
Blood Stem Cells
CAR-T Therapy
Current and Potential Uses
Reprogramming
International Guidelines for the Treatment of Huntington's Disease
Related Topics
Huntington's Disease
Neurological Disorders
Current and Potential Uses
Ethics and Society
Report: ATMPs and equity of access
Related Topics
Rare Diseases
Current and Potential Uses
Taking part in clinical trials: MRI scans
Related Topics
Parkinson's Disease
Clinical Trials
Current and Potential Uses
Patient Involvement
Unproven Treatments
Taking part in clinical trials: MRI and PET
Related Topics
Neurological Disorders
Parkinson's Disease
Clinical Trials
Current and Potential Uses
Patient Involvement
Unproven Treatments
The value of Patient and Public Involvement: Interviews with PPI contributors
Related Topics
Huntington's Disease
Neurological Disorders
Parkinson's Disease
Cell Therapy
Current and Potential Uses
Patient Involvement
Unproven Treatments
LEARN Study: A checklist for people with Parkinson's Disease considering study participation
Related Topics
Neurological Disorders
Parkinson's Disease
Cell Therapy
Clinical Trials
Current and Potential Uses
Patient Involvement
Unproven Treatments
LEARN Study: Summary of outcomes
Related Topics
Huntington's Disease
Parkinson's Disease
Cell Therapy
Current and Potential Uses
Patient Involvement
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Next page
››
Last page
Last »